Global Avibactam Sodium API Supply, Demand and Key Producers, 2024-2030

Global Avibactam Sodium API Supply, Demand and Key Producers, 2024-2030

The global Avibactam Sodium API market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Avibactam sodium and its free acid, avibactam, are diazabicyclooctane (DBO)–based, non-β-lactam β-lactamase inhibitors (BLIs) that are used to treat multi-drug–resistant Gram-negative bacterial pathogens.

This report studies the global Avibactam Sodium API production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Avibactam Sodium API, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Avibactam Sodium API that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Avibactam Sodium API total production and demand, 2019-2030, (Tons)

Global Avibactam Sodium API total production value, 2019-2030, (USD Million)

Global Avibactam Sodium API production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (Tons)

Global Avibactam Sodium API consumption by region & country, CAGR, 2019-2030 & (Tons)

U.S. VS China: Avibactam Sodium API domestic production, consumption, key domestic manufacturers and share

Global Avibactam Sodium API production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (Tons)

Global Avibactam Sodium API production by Type, production, value, CAGR, 2019-2030, (USD Million) & (Tons)

Global Avibactam Sodium API production by Application production, value, CAGR, 2019-2030, (USD Million) & (Tons).

This reports profiles key players in the global Avibactam Sodium API market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cayman Chemical, ACS Dobfar SpA, Chemvon Biotechnology, Sandoo Pharmaceuticals, Jiangxi Fushine Pharmaceutical, Jingjing Pharmaceutical, Xiamen Origin Biotech and Changzhou Red Sun Pharmaceutical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Avibactam Sodium API market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/Kg) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Avibactam Sodium API Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Avibactam Sodium API Market, Segmentation by Type
Purity 95%
Purity 98%

Global Avibactam Sodium API Market, Segmentation by Application
Injections
Oral Preparations

Companies Profiled:
Cayman Chemical
ACS Dobfar SpA
Chemvon Biotechnology
Sandoo Pharmaceuticals
Jiangxi Fushine Pharmaceutical
Jingjing Pharmaceutical
Xiamen Origin Biotech
Changzhou Red Sun Pharmaceutical

Key Questions Answered

1. How big is the global Avibactam Sodium API market?

2. What is the demand of the global Avibactam Sodium API market?

3. What is the year over year growth of the global Avibactam Sodium API market?

4. What is the production and production value of the global Avibactam Sodium API market?

5. Who are the key producers in the global Avibactam Sodium API market?